An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection
Science Immunology · 30.05.2025 · 10 (107)
DOI: 10.1126/sciimmunol.ado5986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 30.05.2025. Verfasst von Rachael L Philips und 14 weiteren Autor:innen. Beteiligte Einrichtung: Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch (MIIB), National Institute of Arthritis, Musculoskeletal and Skin Disea…. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, STAT4 Transcription Factor, Immunity, Innate, Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Interferonopathies drive autoimmunity but can also impair host responses to pathogens, including viral infections. To better understand viral susceptibility of patients with STAT1 gain-of-function (GOF) mutations, we generated conditional knockin mouse models to elucidate disease mechanisms and relevance of different immune subsets. Virally infected Stat1 GOF mice exhibited impaired early IFN-γ production from innate lymphocytes and lethality because of excess prolonged multicytokine production. The presence of the Stat1 GOF allele resulted in premature usage of interferon-stimulated gene factor 3 (ISGF3) over the normal STAT4–AP-1–dependent transcriptomic program in activated innate lymphocytes. Administration of anti–IFN-γ antibodies in wild-type (WT) mice after infection phenocopied Stat1 GOF mice presenting exaggerated inflammation despite viral control. Conversely, early administration of exogenous IFN-γ to infected Stat1 GOF mice prevented lethality and exaggerated cytokine response. Although Stat1 GOF mutations facilitate IFN-γ–mediated autoimmunity, early IFN-γ responses to viral infection via a normal STAT4 program were impaired, leading to overcompensated inflammatory responses in Stat1 GOF mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lymphocyte Cell Biology Section, Molecular Immunology and Inflammation Branch (MIIB), National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), Bethesda, MD 20892, USA.
- National Institutes of General Medical Sciences, Bethesda, MD 20892, USA.
- Department of Microbiology and Immunology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA.
- Lymphocyte Signaling Unit, MIIB, NIAMS, Bethesda, MD 20892, USA.
- Biodata Mining and Discovery Section, NIAMS, Bethesda, MD 20892, USA.
- Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
ORCID-Profile: Rachael L Philips, Yi-Chu Liao, Colleen M Lau, Tasha A Morrison, Kan Jiang, Justin Shayne, Chen Yao, Joseph C Sun, Heather D Hickman, Steve Holland, Yuka Kanno, Michail S Lionakis, John J O'Shea
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- Intramural NIH HHS
Zitieren
APA
Philips, R. L., Liao, Y. C., Lau, C. M., Morrison, T. A., Jiang, K., Hutchinson, A., Shayne, J., Yao, C., Sun, J. C., Hickman, H. D., Milner, J. D., Holland, S., Kanno, Y., Lionakis, M. S., & O'Shea, J. J. (2025). An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection. Science Immunology, 10(107). https://doi.org/10.1126/sciimmunol.ado5986
Vancouver
Philips RL, Liao YC, Lau CM, Morrison TA, Jiang K, Hutchinson A, et al. An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection. Science Immunology. 2025;10(107). doi:10.1126/sciimmunol.ado5986
BibTeX
@article{Philips2025,
author = {Philips, Rachael L and Liao, Yi-Chu and Lau, Colleen M and Morrison, Tasha A and Jiang, Kan and Hutchinson, Amal and Shayne, Justin and Yao, Chen and Sun, Joseph C and Hickman, Heather D and Milner, Joshua D and Holland, Steve and Kanno, Yuka and Lionakis, Michail S and O'Shea, John J},
title = {An activating Stat1 mutant disrupts normal STAT4 innate lymphocyte programs during viral infection},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {107},
doi = {10.1126/sciimmunol.ado5986}
}
EUVIMED